Stock Price Quote

PANACEA BIOTEC LTD.

NSE : PANACEABIOBSE : 531349ISIN CODE : INE922B01023Industry : Pharmaceuticals & DrugsHouse : Soshil Kumar Jain
BSE182.351.5 (+0.83 %)
PREV CLOSE ( ) 180.85
OPEN PRICE ( ) 181.45
BID PRICE (QTY) 182.00 (10)
OFFER PRICE (QTY) 182.25 (50)
VOLUME 462
TODAY'S LOW / HIGH ( )181.40 182.35
52 WK LOW / HIGH ( )90 263
NSE182.901.85 (+1.02 %)
PREV CLOSE( ) 181.05
OPEN PRICE ( ) 182.95
BID PRICE (QTY) 182.70 (15)
OFFER PRICE (QTY) 182.95 (2563)
VOLUME 4579
TODAY'S LOW / HIGH( ) 180.65 182.95
52 WK LOW / HIGH ( )85.95 263.35
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1984
Management Info
Soshil Kumar Jain - Chairman Rajesh Jain - Managing Director
Registered Office

Address Ambala - Chandigarh Highway,,,
Lalru,
Punjab-140501

Phone 01762- 505900

Email investorgrievances@panaceabiotec.com

Website www.panacea-biotec.com

Registrars Details
Skyline Financial Services Pvt Ltd
D-153/A, 1st Floor,Okhla Industrial Area,Phase - I,New Delhi
Listing : BSE, NSE, MCX

NEWS

05Oct Panacea Biotec gets warning letter fro
Panacea Biotec has received warning letter from US Food and Drug Adminis..
24Sep Panacea Biotec completes Phase 1/11 st
Panacea Biotec has successfully completed its Phase I/II study to evalua..
24Sep Panacea Biotec touches roof on complet
Panacea Biotec is currently trading at its upper limit of Rs. 196.80, up..
18Sep Scheme of Arrangement
NOTICESNotice No. 20200917-40 Notice Date 17 Sep 2020Category Co..
24Aug Panacea Biotec terminates MoU with Ref
Panacea Biotec has terminated Memorandum of Understanding (MOU) with Ref..

Financials

in Millions
QTR Jun 20 ANNUAL 20
Net Profit-88.4-1530.8
Gross Profit -81 -789.300000000001
Operating Profit 3.5-313.5
Net Sales 764.81580.9

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Valiant Organics (BSE)
peergroup  3565.00 (8.61%)
M.Cap ( in Cr)4805.42
Torrent Pharma (BSE)
peergroup  2798.45 (3.10%)
M.Cap ( in Cr)47112.78
Pfizer (BSE)
peergroup  5110.00 (0.95%)
M.Cap ( in Cr)23491.46
Astrazeneca Pharma I (BSE)
peergroup  4263.95 (0.77%)
M.Cap ( in Cr)10606.00
Mercury Laboratories (BSE)
peergroup  464.00 (7.43%)
M.Cap ( in Cr)56.40

Shareholding Pattern

PROMOTERS 73.59%
NON-INSTITUTION 25.08%
MUTUAL FUNDS/UTI 1.28%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

Mf Holdings

Scheme NameHold(%)
ICICI Pru Pharma He...0.71

About Panacea Biotec Ltd.

Panacea Biotec Ltd. was incorporated in the year 1984. Its today's share price is 180.85. Its current market capitalisation stands at Rs 1113.84 Cr. In the latest quarter, company has reported Gross Sales of Rs. 4566.96 Cr and Total Income of Rs.4617.56 Cr. The company's management includes Shantanu Yeshwant Nalavadi, R L Narasimhan, N N Khamitkar, Mukul Gupta, Manjula Upadhyay, K M Lal, Bhupinder Singh, Ashwini Luthra, Ankesh Jain, Sumit Jain, Sunanda Jain, Sandeep Jain, Rajesh Jain, Soshil Kumar Jain.

It is listed on the BSE with a BSE Code of 531349 , NSE with an NSE Symbol of PANACEABIO and ISIN of INE922B01023. It's Registered office is at Ambala - Chandigarh Highway,,Lalru-140501, Punjab. Their Registrars are ACC Ltd. It's auditors are SR Batliboi & Co LLP, Walker Chandiok & Co, Walker Chandiok & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)